In several studies, an enhanced expression of IGF2BP proteins could be demonstrated in various tumor entities, with IGF2BP1 and IGF2BP3 showing bona-fide oncofetal, but distinguished expression patterns [15,16]. Here, IGF2BP1 is linked to neoplasm.